Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis.
Aharoni R, Saada R, Eilam R, Hayardeny L, Sela M, Arnon R
J Neuroimmunol. 2012 Jun 28. PMID: 22749337.Abstract